{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T01:14:35Z","timestamp":1780449275648,"version":"3.54.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T00:00:00Z","timestamp":1749254400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T00:00:00Z","timestamp":1749254400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Virol"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s00705-025-06339-w","type":"journal-article","created":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T16:57:26Z","timestamp":1749315446000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Single-particle quantification of SARS-CoV-2 virus-like particles using flow virometry"],"prefix":"10.1007","volume":"170","author":[{"given":"Hyeop","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye Rae","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9014-9145","authenticated-orcid":false,"given":"Yong Tae","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,7]]},"reference":[{"issue":"12","key":"6339_CR1","doi-asserted-by":"publisher","first-page":"e3001016","DOI":"10.1371\/journal.pbio.3001016","volume":"18","author":"C Conceicao","year":"2020","unstructured":"Conceicao C, Thakur N, Human S, Kelly JT, Logan L, Bialy D, Bhat S, Stevenson-Leggett P, Zagrajek AK, Hollinghurst P, Varga M, Tsirigoti C, Tully M, Chiu C, Moffat K, Silesian AP, Hammond JA, Maier HJ, Bickerton E, Shelton H, Dietrich I, Graham SC, Bailey D (2020) The SARS-CoV-2 Spike protein has a broad tropism for mammalian ACE2 proteins. PLoS Biol 18(12):e3001016. https:\/\/doi.org\/10.1371\/journal.pbio.3001016","journal-title":"PLoS Biol"},{"key":"6339_CR2","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann M, Kleine-Weber H, Schroeder S, Kr\u00fcger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, M\u00fcller MA, Drosten C, P\u00f6hlmann S (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181:271\u2013280. https:\/\/doi.org\/10.1016\/j.cell.2020.02.052","journal-title":"Cell"},{"key":"6339_CR3","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s12964-023-01104-5","volume":"21","author":"S Kakavandi","year":"2023","unstructured":"Kakavandi S, Zare I, VaezJalali M, Dadashi M, Azarian M, Akbari A, Ramezani Farani M, Zalpoor H, Hajikhani B (2023) Structural and non-structural proteins in SARS-CoV-2: potential aspects to COVID-19 treatment or prevention of progression of related diseases. Cell Commun Signal 21:110. https:\/\/doi.org\/10.1186\/s12964-023-01104-5","journal-title":"Cell Commun Signal"},{"key":"6339_CR4","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","volume":"395","author":"R Lu","year":"2020","unstructured":"Lu R, Zhao X, Li J, Niu P, Yang B, Wu H et al (2020) Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding. Lancet 395:565\u2013574. https:\/\/doi.org\/10.1016\/S0140-6736(20)30251-8","journal-title":"Lancet"},{"key":"6339_CR5","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/s41586-020-2179-y","volume":"581","author":"J Shang","year":"2020","unstructured":"Shang J, Ye G, Shi K, Wan Y, Luo C, Aihara H, Geng Q, Auerbach A, Li F (2020) Structural basis of receptor recognition by SARS-CoV-2. Nature 581:221\u2013224. https:\/\/doi.org\/10.1038\/s41586-020-2179-y","journal-title":"Nature"},{"key":"6339_CR6","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12951-021-00806-7","volume":"19","author":"S Nooraei","year":"2021","unstructured":"Nooraei S, Bahrulolum H, Hoseini ZS, Katalani C, Hajizade A, Easton AJ, Ahmadian G (2021) Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers. J Nanobiotechnol 19:59. https:\/\/doi.org\/10.1186\/s12951-021-00806-7","journal-title":"J Nanobiotechnol"},{"key":"6339_CR7","doi-asserted-by":"publisher","unstructured":"Hirschberg S, Bauer H, Kamhieh-Milz J, Ringel F, Harms C, Eddin OK, Pru\u00df A, Hanack K, Schulze-Forster K (2022) SARS-CoV-2 Virus-like Particles (VLPs) Specifically Detect Humoral Immune Reactions in an ELISA-Based Platform. Antibodies (Basel). 11:76. https:\/\/doi.org\/10.3390\/antib11040076","DOI":"10.3390\/antib11040076"},{"key":"6339_CR8","doi-asserted-by":"publisher","first-page":"045","DOI":"10.1093\/pnasnexus\/pgac045","volume":"1","author":"J Roessler","year":"2021","unstructured":"Roessler J, Pich D, Albanese M, Wratil PR, Kr\u00e4hling V, Hellmuth JC, Scherer C, von Bergwelt-Baildon M, Becker S, Keppler OT, Brisson A, Zeidler R, Hammerschmidt W (2021) Quantitation of SARS-CoV-2 neutralizing antibodies with a virus-free, authentic test. PNAS Nexus 1:045. https:\/\/doi.org\/10.1093\/pnasnexus\/pgac045","journal-title":"PNAS Nexus"},{"key":"6339_CR9","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1021\/acsinfecdis.2c00217","volume":"8","author":"CS Kumar","year":"2022","unstructured":"Kumar CS, Singh B, Rizvi ZA, Parray HA, Verma JK, Ghosh S, Mukhopadhyay A, Awasthi A, Shrivastava T, Banerjee M (2022) Virus-Like Particles of SARS-CoV-2 as Virus Surrogates: Morphology, Immunogenicity, and Internalization in Neuronal Cells. ACS Infect Dis 8:2119\u20132132. https:\/\/doi.org\/10.1021\/acsinfecdis.2c00217","journal-title":"ACS Infect Dis"},{"key":"6339_CR10","doi-asserted-by":"publisher","first-page":"21877","DOI":"10.1038\/s41598-020-78656-w","volume":"10","author":"H Swann","year":"2020","unstructured":"Swann H, Sharma A, Preece B, Peterson A, Eldredge C, Belnap DM, Vershinin M, Saffarian S (2020) Minimal system for assembly of SARS-CoV-2 virus like particles. Sci Rep 10:21877. https:\/\/doi.org\/10.1038\/s41598-020-78656-w","journal-title":"Sci Rep"},{"key":"6339_CR11","doi-asserted-by":"publisher","first-page":"862","DOI":"10.3389\/fbioe.2020.00862","volume":"8","author":"R Xu","year":"2020","unstructured":"Xu R, Shi M, Li J, Song P, Li N (2020) Construction of SARS-CoV-2 Virus-Like Particles by Mammalian Expression System. Front Bioeng Biotechnol 8:862. https:\/\/doi.org\/10.3389\/fbioe.2020.00862","journal-title":"Front Bioeng Biotechnol"},{"key":"6339_CR12","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/s43856-023-00340-7","volume":"3","author":"SP Alpuche-Lazcano","year":"2023","unstructured":"Alpuche-Lazcano SP, Stuible M, Akache B, Tran A, Kelly J, Hrapovic S, Robotham A, Haqqani A, Star A, Renner TM, Blouin J, Maltais JS, Cass B, Cui K, Cho JY, Wang X, Zoubchenok D, Dudani R, Duque D, McCluskie MJ, Durocher Y (2023) Preclinical evaluation of manufacturable SARS-CoV-2 spike virus-like particles produced in Chinese Hamster Ovary cells. Commun Med (Lond) 3:116. https:\/\/doi.org\/10.1038\/s43856-023-00340-7","journal-title":"Commun Med (Lond)"},{"key":"6339_CR13","doi-asserted-by":"publisher","first-page":"100111","DOI":"10.1074\/jbc.RA120.016175","volume":"296","author":"B Boson","year":"2021","unstructured":"Boson B, Legros V, Zhou B, Siret E, Mathieu C, Cosset FL, Lavillette D, Denolly S (2021) The SARS-CoV-2 envelope and membrane proteins modulate maturation and retention of the spike protein, allowing assembly of virus-like particles. J Biol Chem 296:100111. https:\/\/doi.org\/10.1074\/jbc.RA120.016175","journal-title":"J Biol Chem"},{"key":"6339_CR14","doi-asserted-by":"publisher","first-page":"3889","DOI":"10.7150\/ijbs.64977","volume":"17","author":"M Chen","year":"2021","unstructured":"Chen M, Yan C, Qin F, Zheng L, Zhang XE (2021) The intraviral protein-protein interaction of SARS-CoV-2 reveals the key role of N protein in virus-like particle assembly. Int J Biol Sci 17:3889\u20133897. https:\/\/doi.org\/10.7150\/ijbs.64977","journal-title":"Int J Biol Sci"},{"key":"6339_CR15","doi-asserted-by":"publisher","first-page":"e0237121","DOI":"10.1128\/mBio.02371-21","volume":"12","author":"D Bracquemond","year":"2021","unstructured":"Bracquemond D, Muriaux D (2021) Betacoronavirus Assembly: Clues and Perspectives for Elucidating SARS-CoV-2 Particle Formation and Egress. mBio 12:e0237121. https:\/\/doi.org\/10.1128\/mBio.02371-21","journal-title":"mBio"},{"key":"6339_CR16","doi-asserted-by":"publisher","first-page":"114835","DOI":"10.1016\/j.jviromet.2023.114835","volume":"322","author":"G Elfayres","year":"2023","unstructured":"Elfayres G, Paswan RR, Sika L, Girard MP, Khalfi S, Letanneur C, Milette K, Singh A, Kobinger G, Berthoux L (2023) Mammalian cells-based platforms for the generation of SARS-CoV-2 virus-like particles. J Virol Methods 322:114835. https:\/\/doi.org\/10.1016\/j.jviromet.2023.114835","journal-title":"J Virol Methods"},{"key":"6339_CR17","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.3390\/vaccines11091469","volume":"11","author":"S Hirschberg","year":"2023","unstructured":"Hirschberg S, Ghazaani F, Ben Amor G, Pydde M, Nagel A, Germani S, Monica L, Schl\u00f6r A, Bauer H, Hornung J, Voetz M, Dwai Y, Scheer B, Ringel F, Kamal-Eddin O, Harms C, F\u00fcner J, Adrian L, Pru\u00df A, Schulze-Forster K, Hanack K, Kamhieh-Milz J (2023) An Efficient and Scalable Method for the Production of Immunogenic SARS-CoV-2 Virus-like Particles (VLP) from a Mammalian Suspension Cell Line. Vaccines (Basel) 11:1469. https:\/\/doi.org\/10.3390\/vaccines11091469","journal-title":"Vaccines (Basel)"},{"key":"6339_CR18","doi-asserted-by":"publisher","unstructured":"Jaron M, Lehky M, Zar\u00e0 M, Zaydowicz CN, Lak A, Ballmann R, Heine PA, Wenzel EV, Schneider KT, Bertoglio F, Kempter S, K\u00f6ster RW, Barbieri SS, van den Heuvel J, Hust M, D\u00fcbel S, Schubert M (2022) Baculovirus-Free SARS-CoV-2 Virus-like Particle Production in Insect Cells for Rapid Neutralization Assessment. Viruses. 14: 2087. https:\/\/doi.org\/10.3390\/v14102087","DOI":"10.3390\/v14102087"},{"key":"6339_CR19","doi-asserted-by":"publisher","unstructured":"Mi Y, Xie T, Zhu B, Tan J, Li X, Luo Y, Li F, Niu H, Han J, Lv W, Wang J (2021) Production of SARS-CoV-2 Virus-Like Particles in insect cells.Vaccines (Basel). 9:554. https:\/\/doi.org\/10.3390\/vaccines9060554","DOI":"10.3390\/vaccines9060554"},{"key":"6339_CR20","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/s41598-022-04883-y","volume":"12","author":"KB Moon","year":"2022","unstructured":"Moon KB, Jeon JH, Choi H, Park JS, Park SJ, Lee HJ, Park JM, Cho HS, Moon JS, Oh H, Kang S, Mason HS, Kwon SY, Kim HS (2022) Construction of SARS-CoV-2 virus-like particles in plant. Sci Rep 12:1005. https:\/\/doi.org\/10.1038\/s41598-022-04883-y","journal-title":"Sci Rep"},{"key":"6339_CR21","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.3390\/v14122825","volume":"14","author":"YS Chang","year":"2022","unstructured":"Chang YS, Chu LW, Chen ZY, Wu JS, Su WC, Yang CJ, Ping YH, Lin CW (2022) Development of Fluorescence-Tagged SARS-CoV-2 Virus-like Particles by a Tri-Cistronic Vector Expression System for Investigating the Cellular Entry of SARS-CoV-2. Viruses 14:2825. https:\/\/doi.org\/10.3390\/v14122825","journal-title":"Viruses"},{"key":"6339_CR22","doi-asserted-by":"publisher","first-page":"14651","DOI":"10.1038\/s41598-022-18681-z","volume":"12","author":"M Gourdelier","year":"2022","unstructured":"Gourdelier M, Swain J, Arone C, Mouttou A, Bracquemond D, Merida P, Saffarian S, Lyonnais S, Favard C, Muriaux D (2022) Optimized production and fluorescent labeling of SARS-CoV-2 virus-like particles. Sci Rep 12:14651. https:\/\/doi.org\/10.1038\/s41598-022-18681-z","journal-title":"Sci Rep"},{"key":"6339_CR23","doi-asserted-by":"publisher","first-page":"100103","DOI":"10.1074\/jbc.RA120.016148","volume":"296","author":"CB Plescia","year":"2021","unstructured":"Plescia CB, David EA, Patra D, Sengupta R, Amiar S, Su Y, Stahelin RV (2021) SARS-CoV-2 viral budding and entry can be modeled using BSL-2 level virus-like particles. J Biol Chem 296:100103. https:\/\/doi.org\/10.1074\/jbc.RA120.016148","journal-title":"J Biol Chem"},{"key":"6339_CR24","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.3390\/v12111296","volume":"12","author":"J Burnie","year":"2020","unstructured":"Burnie J, Tang VA, Welsh JA, Persaud AT, Thaya L, Jones JC, Guzzo C (2020) Flow Virometry Quantification of Host Proteins on the Surface of HIV-1 Pseudovirus Particles. Viruses 12:1296. https:\/\/doi.org\/10.3390\/v12111296","journal-title":"Viruses"},{"key":"6339_CR25","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3390\/v12020223","volume":"12","author":"I Gonz\u00e1lez-Dom\u00ednguez","year":"2020","unstructured":"Gonz\u00e1lez-Dom\u00ednguez I, Puente-Massaguer E, Cervera L, G\u00f2dia F (2020) Quality Assessment of Virus-Like Particles at Single Particle Level: A Comparative Study. Viruses 12:223. https:\/\/doi.org\/10.3390\/v12020223","journal-title":"Viruses"},{"key":"6339_CR26","doi-asserted-by":"publisher","unstructured":"Khadivjam B, El Bilali N, Lipp\u00e9 R (2020) Analysis and Sorting of Individual HSV-1 Particles by Flow Virometry. Methods Mol Biol 2060: 289\u2013303. https:\/\/doi.org\/10.1007\/978-1-4939-9814-2_16","DOI":"10.1007\/978-1-4939-9814-2_16"},{"key":"6339_CR27","doi-asserted-by":"publisher","first-page":"5529","DOI":"10.1016\/j.vaccine.2022.08.006","volume":"40","author":"A Prout","year":"2022","unstructured":"Prout A, Rustandi RR, Tubbs C, Winters MA, McKenna P, Vlasak J (2022) Functional profiling of Covid 19 vaccine candidate by flow virometry. Vaccine 40:5529\u20135536. https:\/\/doi.org\/10.1016\/j.vaccine.2022.08.006","journal-title":"Vaccine"},{"key":"6339_CR28","doi-asserted-by":"publisher","first-page":"7432","DOI":"10.1038\/s41598-021-86688-z","volume":"11","author":"G Ricci","year":"2021","unstructured":"Ricci G, Minsker K, Kapish A, Osborn J, Ha S, Davide J, Califano JP, Sehlin D, Rustandi RR, Dick LW Jr, Vlasak J, Culp TD, Baudy A, Bell E, Mukherjee M (2021) Flow virometry for process monitoring of live virus vaccines-lessons learned from ERVEBO. Sci Rep 11:7432. https:\/\/doi.org\/10.1038\/s41598-021-86688-z","journal-title":"Sci Rep"},{"key":"6339_CR29","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.chroma.2016.12.085","volume":"1487","author":"P Steppert","year":"2017","unstructured":"Steppert P, Burgstaller D, Klausberger M, Tover A, Berger E, Jungbauer A (2017) Quantification and characterization of virus-like particles by size-exclusion chromatography and nanoparticle tracking analysis. J Chromatogr A 1487:89\u201399. https:\/\/doi.org\/10.1016\/j.chroma.2016.12.085","journal-title":"J Chromatogr A"},{"key":"6339_CR30","doi-asserted-by":"publisher","first-page":"853","DOI":"10.3390\/cells10040853","volume":"10","author":"B Kumar","year":"2021","unstructured":"Kumar B, Hawkins GM, Kicmal T, Qing E, Timm E, Gallagher T (2021) Assembly and Entry of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2): Evaluation Using Virus-Like Particles. Cells 10:853. https:\/\/doi.org\/10.3390\/cells10040853","journal-title":"Cells"},{"key":"6339_CR31","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1126\/science.abl6184","volume":"374","author":"AM Syed","year":"2021","unstructured":"Syed AM, Taha TY, Tabata T, Chen IP, Ciling A, Khalid MM, Sreekumar B, Chen PY, Hayashi JM, Soczek KM, Ott M, Doudna JA (2021) Rapid assessment of SARS-CoV-2-evolved variants using virus-like particles. Science 374:1626\u20131632. https:\/\/doi.org\/10.1126\/science.abl6184","journal-title":"Science"},{"key":"6339_CR32","doi-asserted-by":"publisher","first-page":"198305","DOI":"10.1016\/j.virusres.2021.198305","volume":"295","author":"S Roy","year":"2021","unstructured":"Roy S, Ghani K, de Campos-Lima PO, Caruso M (2021) A stable platform for the production of virus-like particles pseudotyped with the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) spike protein. Virus Res 295:198305. https:\/\/doi.org\/10.1016\/j.virusres.2021.198305","journal-title":"Virus Res"},{"key":"6339_CR33","doi-asserted-by":"publisher","first-page":"4516","DOI":"10.1021\/acs.jproteome.0c00581","volume":"19","author":"J Lavado-Garc\u00eda","year":"2020","unstructured":"Lavado-Garc\u00eda J, Gonz\u00e1lez-Dom\u00ednguez I, Cervera L, Jorge I, V\u00e1zquez J, G\u00f2dia F (2020) Molecular Characterization of the Coproduced Extracellular Vesicles in HEK293 during Virus-Like Particle Production. J Proteome Res 19:4516\u20134532. https:\/\/doi.org\/10.1021\/acs.jproteome.0c00581","journal-title":"J Proteome Res"}],"container-title":["Archives of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-025-06339-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00705-025-06339-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-025-06339-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T07:10:16Z","timestamp":1751613016000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00705-025-06339-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,7]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["6339"],"URL":"https:\/\/doi.org\/10.1007\/s00705-025-06339-w","relation":{},"ISSN":["0304-8608","1432-8798"],"issn-type":[{"value":"0304-8608","type":"print"},{"value":"1432-8798","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,7]]},"assertion":[{"value":"6 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors of this study have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"149"}}